Tesamorelin, Ipamorelin 10/3 (Blend)

▎Ipamorelin

As a synthetic pentapeptide compound, Ipamorelin, as an important member of the growth hormone secretagogue family, achieves precise regulation of the growth hormone secretion axis by virtue of its unique molecular structure design. This compound binds with high affinity to the growth hormone secretagogue receptor (GHS-R), activates the downstream signaling pathway, efficiently induces the pulsatile release of growth hormone (GH), and simultaneously promotes the gene expression and protein synthesis of insulin-like growth factor-1 (IGF-1). This dual mechanism of action not only regulates the energy metabolism process (including promoting amino acid uptake, accelerating protein synthesis, and optimizing fat catabolism) but also plays a positive regulatory role in tissue repair and growth by enhancing the cell proliferation signal.

In clinical studies, Ipamorelin has demonstrated multi-system regulatory effects. Its effect on improving gastrointestinal motility is manifested as accelerating the gastric emptying rate. Especially in the state of postoperative ileus, by promoting the peristaltic frequency and contraction intensity of gastrointestinal smooth muscles, it effectively relieves intestinal motor dysfunction. In the field of pain management, this compound regulates nociceptive signal transduction through both central and peripheral pathways and shows a significant relieving effect on non-inflammatory visceral pain and somatic pain. Its mechanism of action may involve the activation of the endogenous opioid peptide system and the regulation of ion channel activity.

Compared with traditional growth hormone secretagogues, the significant advantage of Ipamorelin lies in its high selectivity for growth hormone release. While effectively stimulating GH secretion, this compound has no significant effect on the secretion of other pituitary-adrenal axis hormones such as adrenocorticotropic hormone (ACTH) and cortisol, thus reducing the risk of adverse reactions caused by hormonal disorders. This pharmacological property endows it with the potential for precise intervention in the replacement therapy of growth hormone deficiency, and at the same time provides a new drug target for the research on the pathogenesis of gastrointestinal motility disorders and the optimization of pain diagnosis and treatment programs.

▎Summary

1. Growth Hormone Regulation

Synergistic Mechanism:

Tesamoreli stimulates the secretion of growth hormone (GH) from the anterior pituitary gland by activating the growth hormone-releasing hormone (GHRH) receptor, while Ipamorelin promotes the pulsatile secretion of GH by selectively activating the growth hormone secretagogue receptor (GHSR).

When used in combination, the two can enhance the secretion of GH from different pathways, forming a synergistic effect and thus significantly increasing the level of GH in the body.

Balance and Control of GH Secretion:

Ipamorelin avoids the risk of excessive GH stimulation by mimicking the natural pulsatile secretion pattern of GH, while Tesamoreli provides a stable basis for GH secretion through the GHRH pathway. This combined use can maintain the GH level while ensuring the rhythmicity and balance of its secretion.

2. Metabolic Optimization

Lipid Metabolism:

Tesamoreli reduces visceral fat by enhancing fat breakdown and improving lipid metabolism, while Ipamorelin further accelerates fat metabolism by promoting fatty acid oxidation. When used in combination, the two can jointly optimize lipid metabolism, reduce age-related fat accumulation, and improve insulin sensitivity.

Glucose Metabolism:

Tesamoreli reduces the risk of metabolic disorders by improving the efficiency of glucose utilization, while Ipamorelin protects muscle tissue and avoids energy loss through its anti-catabolic effect.

This synergistic effect helps maintain metabolic balance and supports healthy aging.

3. Tissue Support and Repair

Protein Synthesis and Cell Renewal:

Tesamoreli promotes tissue repair and regeneration by stimulating protein synthesis and cell renewal, while Ipamorelin prevents muscle breakdown by protecting the existing tissue structure. When used in combination, the two can provide comprehensive tissue support, both promoting the repair of damaged tissues and protecting the existing tissues from being damaged.

Anti-aging Effect:

The increase in GH level is closely related to the anti-aging effect. The combined use of Tesamoreli and Ipamorelin can delay cell aging, improve skin elasticity, reduce wrinkles, and support bone health.

4. Anti-aging and Cognitive Benefits

Neuroprotection and Cognitive Function:

GH plays an important role in brain function and neuroprotection. The combined use of these two peptides can improve cognitive function and reduce age-related cognitive decline by regulating the GH level.

Systemic Resilience:

By balancing GH secretion and optimizing metabolism, the combined use can enhance the systemic resilience of the body and support long-term health and functional capacity.

About The Author

The above-mentioned materials are all researched, edited and compiled by Cocer Peptides.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.  

The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.